Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 3 de 3
1.
J Med Syst ; 48(1): 39, 2024 Apr 05.
Article En | MEDLINE | ID: mdl-38578467

Transvaginal oocyte retrieval is an outpatient procedure performed under local anaesthesia. Hypno-analgesia could be effective in managing comfort during this procedure. This study aimed to assess the effectiveness of a virtual reality headset as an adjunct to local anaesthesia in managing nociception during oocyte retrieval. This was a prospective, randomized single-centre study including patients undergoing oocyte retrieval under local anaesthesia. Patients were randomly assigned to the intervention group (virtual reality headset + local anaesthesia) or the control group (local anaesthesia). The primary outcome was the efficacy on the ANI®, which reflects the relative parasympathetic tone. Secondary outcomes included pain, anxiety, conversion to general anaesthesia rate, procedural duration, patient's and gynaecologist's satisfaction and virtual reality headset tolerance. ANI was significantly lower in the virtual reality group during the whole procedure (mean ANI: 79 95 CI [77; 81] vs 74 95 CI [72; 76]; p < 0.001; effect size Cohen's d -0.53 [-0.83, -0.23]), and during the two most painful moments: infiltration (mean ANI: 81 +/- 11 vs 74 +/- 13; p < 0.001; effect size Cohen's d -0.54[-0.85, -0.24]) and oocytes retrieval (mean ANI: 78 +/- 11 vs 74.40 +/- 11; p = 0.020; effect size Cohen's d -0.37 [-0.67, -0.07]).There was no significant difference in pain measured by VAS. No serious adverse events related were reported. The integration of virtual reality as an hypnotic tool during oocyte retrieval under local anaesthesia in assisted reproductive techniques could improve patient's comfort and experience.


Anesthesia, Local , Virtual Reality , Humans , Oocyte Retrieval/adverse effects , Oocyte Retrieval/methods , Prospective Studies , Pain/etiology
2.
Fertil Steril ; 96(4): 872-6, 2011 Oct.
Article En | MEDLINE | ID: mdl-21868004

OBJECTIVE: To verify whether a variable number of days beyond the menses of estrogen (E) pretreatment may impact on controlled ovarian hyperstimulation (COH) outcomes and birth rate using a GnRH antagonist protocol. DESIGN: Single center, prospective, nonrandomized study. SETTING: Nonacademic fertility unit. PATIENT(S): A total of 1,080 women, aged 25-38 years, consecutively included (1,603 cycles). INTERVENTION(S): Given 4 mg/d E(2) valerate, started 3 days before the theoretical date of the next menses up to the first day of stimulation (S1). MAIN OUTCOME MEASURE(S): Hormone serum levels, drug exposure, and main IVF outcomes. RESULT(S): The cancellation rate was similar in the six similarly sized groups according to the number of days with E(2) pretreatment beyond the menses (1-8 days). The mean serum E(2) and LH levels at S1 gradually increased along with E(2) exposure, whereas the mean serum P level decreased. The mean serum E(2) level on the day of hCG administration gradually increased along with E(2) exposure. Serum LH level at S1 correlated significantly and positively to the length of E(2) exposure and to E(2) level on the day of hCG administration. No significant difference was observed for the number of oocytes retrieved and the number of embryos obtained. Women exposed the longest to exogenous E(2) tended to have higher pregnancy rates (PR). CONCLUSION(S): Extending E(2) pretreatment beyond the menses had no deleterious effect on the main COH outcomes and proved to be slightly beneficial.


Estrogens/administration & dosage , Fertilization in Vitro/methods , Gonadotropin-Releasing Hormone/antagonists & inhibitors , Oocyte Retrieval/methods , Ovarian Hyperstimulation Syndrome , Ovulation Induction/methods , Adult , Estradiol/administration & dosage , Estradiol/blood , Estrogens/blood , Female , Gonadotropin-Releasing Hormone/blood , Humans , Ovarian Hyperstimulation Syndrome/blood , Ovarian Hyperstimulation Syndrome/etiology , Pregnancy , Pregnancy Rate/trends , Prospective Studies , Retrospective Studies , Time Factors
3.
Fertil Steril ; 90(4): 1201.e13-7, 2008 Oct.
Article En | MEDLINE | ID: mdl-18166187

OBJECTIVE: To determine the meiotic segregation in large-headed, multiple-tailed spermatozoa. DESIGN: Analysis of sperm nuclei by fluorescence in situ hybridization (FISH). SETTING: University hospital. PATIENT(S): A 34-year-old man with 100% morphologically abnormal spermatozoa. INTERVENTION(S): Dual-color FISH for chromosomes 13 and 21 and triple-color FISH for chromosomes X, Y, and 18 were performed. MAIN OUTCOME MEASURE(S): Aneuploidy rates. RESULT(S): More than 99% of the spermatozoa had abnormal content for chromosomes X, Y, 13, 18, and 21. Diploidy, triploidy, and tetraploidy rates were found to be 18.42%, 6.14%, and 33.99% in triple-color FISH and to be 16.09%, 16.28%, and 38.95% in dual-color FISH. CONCLUSION(S): Our results and those from other investigators show that large-headed, multiple-tailed spermatozoa are associated with a high rate of polyploidy and aneuploidy. Intracytoplasmic sperm injection should not be recommended to those patients, not only because of its low success rate but also because of its high genetic risk.


Aneuploidy , Azoospermia/genetics , Azoospermia/pathology , Oligospermia/genetics , Oligospermia/pathology , Sperm Head/pathology , Sperm Tail/pathology , Humans , Male , Middle Aged , Oligospermia/diagnosis
...